Closed 16 of 18 events
Threads / MHRA Patient Engagement Policy / Timeline
Lifecycle stage Response Published
813 days in stage

MHRA Patient Engagement Policy

The Medicines and Healthcare products Regulatory Agency (MHRA) is developing a Patient Engagement and Public Involvement Strategy to improve how it communicates with patients and healthcare professionals about medicines and medical devices safety. This active policy includes consultations on safety communications, prescription-only medicine proposals (such as Codeine Linctus), and addressing patient concerns about regulatory decisions affecting them.

Log in for AI briefing
Showing 16 of 18 signals
Sort Latest first Oldest first
Family 1
Signal
Year
Body
Role
Clear all
Family: Consultations
20 Feb 2024 | Consultation outcome Medicines and Healthcare products Regulatory Agency linked

MHRA Public consultation on the proposal to make Codeine Linctus available as a prescription-only medicine (POM) — outcome published

The Medicines and Healthcare Products Regulatory Agency (MHRA) have launched a public consultation to propose reclassification of Codeine Linctus to prescription-only medicine.

▤ View document · ↗ GOV.UK · ↓ Proposal to make Codeine Linctus and Codeine Or… (31pp)
+2 more
↓ Consultation response on proposal to make codeine linctus a… ↓ Codeine linctus (codeine oral solutions): Proposal to recla… (31pp)
11 Dec 2023 | Consultation outcome Medicines and Healthcare products Regulatory Agency linked

Consultation on how MHRA communicate with healthcare professionals to improve medicines and medical devices’ safety — outcome published

The MHRA is reviewing its approach to engagement with healthcare professionals to improve the safety of medicines and medical devices.

▤ View document · ↗ GOV.UK · ↓ Executive summary of consultation and recommend…
+1 more
↓ Executive summary of consultation and recommendations (46pp)
15 Aug 2023 | Consultation outcome Medicines and Healthcare products Regulatory Agency linked

MHRA Public consultation on the proposal to make Codeine Linctus available as a prescription-only medicine (POM) — consultation closed

The Medicines and Healthcare Products Regulatory Agency (MHRA) have launched a public consultation to propose reclassification of Codeine Linctus to prescription-only medicine.

▤ View document · ↗ GOV.UK · ↓ Proposal to make Codeine Linctus and Codeine Or… (31pp)
+2 more
↓ Consultation response on proposal to make codeine linctus a… ↓ Codeine linctus (codeine oral solutions): Proposal to recla… (31pp)
18 Jul 2023 | Consultation outcome Medicines and Healthcare products Regulatory Agency linked

MHRA Public consultation on the proposal to make Codeine Linctus available as a prescription-only medicine (POM) — consultation opened

The Medicines and Healthcare Products Regulatory Agency (MHRA) have launched a public consultation to propose reclassification of Codeine Linctus to prescription-only medicine.

▤ View document · ↗ GOV.UK · ↓ Proposal to make Codeine Linctus and Codeine Or… (31pp)
+2 more
↓ Consultation response on proposal to make codeine linctus a… ↓ Codeine linctus (codeine oral solutions): Proposal to recla… (31pp)
31 Jan 2023 | Consultation outcome Medicines and Healthcare products Regulatory Agency linked

Consultation on how MHRA communicate with healthcare professionals to improve medicines and medical devices’ safety — consultation closed

The MHRA is reviewing its approach to engagement with healthcare professionals to improve the safety of medicines and medical devices.

▤ View document · ↗ GOV.UK · ↓ Executive summary of consultation and recommend…
+1 more
↓ Executive summary of consultation and recommendations (46pp)
13 Oct 2022 | Consultation outcome Medicines and Healthcare products Regulatory Agency linked

Consultation on how MHRA communicate with healthcare professionals to improve medicines and medical devices’ safety — consultation opened

The MHRA is reviewing its approach to engagement with healthcare professionals to improve the safety of medicines and medical devices.

▤ View document · ↗ GOV.UK · ↓ Executive summary of consultation and recommend…
+1 more
↓ Executive summary of consultation and recommendations (46pp)
15 Jun 2020 | Consultation outcome Medicines and Healthcare products Regulatory Agency linked

How should we engage and involve patients and the public in our work — outcome published

Work is ongoing to address the comments and feedback from respondents to the consultation. Publication of our report on the consultation has been delayed in light of the Agency’s response during the ongoing coronavirus situation.

▤ View document · ↗ GOV.UK · ↓ Privacy notice for consultation on how should w…
+6 more
↓ Response: What we will do differently ↓ Response: What we will do differently (10pp) ↓ What you told us ↓ What you told us (30pp) ↓ List of organisations that responded to the consultation ↓ List of organisations that responded to the consultation (2pp)
7 Oct 2019 | Consultation outcome Medicines and Healthcare products Regulatory Agency linked

How should we engage and involve patients and the public in our work — consultation closed

Work is ongoing to address the comments and feedback from respondents to the consultation. Publication of our report on the consultation has been delayed in light of the Agency’s response during the ongoing coronavirus situation.

▤ View document · ↗ GOV.UK · ↓ Privacy notice for consultation on how should w…
+6 more
↓ Response: What we will do differently ↓ Response: What we will do differently (10pp) ↓ What you told us ↓ What you told us (30pp) ↓ List of organisations that responded to the consultation ↓ List of organisations that responded to the consultation (2pp)
15 Jul 2019 | Consultation outcome Medicines and Healthcare products Regulatory Agency linked

How should we engage and involve patients and the public in our work — consultation opened

Work is ongoing to address the comments and feedback from respondents to the consultation. Publication of our report on the consultation has been delayed in light of the Agency’s response during the ongoing coronavirus situation.

▤ View document · ↗ GOV.UK · ↓ Privacy notice for consultation on how should w…
+6 more
↓ Response: What we will do differently ↓ Response: What we will do differently (10pp) ↓ What you told us ↓ What you told us (30pp) ↓ List of organisations that responded to the consultation ↓ List of organisations that responded to the consultation (2pp)